Biotechnology Companies in the News – December 2011

December 2 Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals for Phase II Combination Study in Patients Chronically Infected with Hepatitis C December 1 NPS Pharmaceuticals Completes Submission of New Drug Application for GATTEX(R) (teduglutide) in Adult Short Bowel Syndrome (SBS) Aegerion Pharmaceuticals to Participate in the 2011 Deutsche Bank BioFEST Conference Amicus Therapeutics… Read the full article


Industry News and Notes – December 2011

Washington Report BIO Applauds Congress for Reauthorizing SBIR/STTR Programs WASHINGTON, DC — The Biotechnology Industry Organization (BIO) on December 16 praised the House and Senate for passage of Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) reauthorization as part of the National Defense Authorization Act (HR 1540). The passage of this Act… Read the full article


Membership Update – December 2011

BioNJ welcomes The Medicines Company as a new Platinum Member for 2011. The Medicines Company The Medicines Company is a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. We have three marketed products: Angiomax® (bivalirudin), Cleviprex® (clevidipine) injectable emulsion,… Read the full article